Dáil Éireann Debate, Wednesday - 26 October 2016
132. Deputy Pearse Doherty asked the Minister for Health when he will make a decision on an application to include the drug Kuvan sapropterin in the drug reimbursement programme; and if he will make a statement on the matter. [32254/16]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
